US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Identifieur interne : 001224 ( Main/Corpus ); précédent : 001223; suivant : 001225US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Auteurs : Nadine Shehab ; Maribeth Lovegrove ; Daniel S. BudnitzSource :
- JAMA internal medicine [ 2168-6114 ] ; 2020.
English descriptors
- KwdEn :
- Anti-Infective Agents (pharmacology), Azithromycin (pharmacology), Betacoronavirus (MeSH), COVID-19 (MeSH), Chloroquine (pharmacology), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Databases, Pharmaceutical (statistics & numerical data), Drug Prescriptions (statistics & numerical data), Humans (MeSH), Hydroxychloroquine (pharmacology), Outpatients (statistics & numerical data), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Practice Patterns, Physicians' (trends), Pre-Exposure Prophylaxis (methods), Prescription Drug Monitoring Programs (statistics & numerical data), SARS-CoV-2 (MeSH), United States (epidemiology).
- MESH :
- chemical , pharmacology : Anti-Infective Agents, Azithromycin, Chloroquine, Hydroxychloroquine.
- geographic , epidemiology : United States.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Pre-Exposure Prophylaxis.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- statistics & numerical data : Databases, Pharmaceutical, Drug Prescriptions, Outpatients, Prescription Drug Monitoring Programs.
- trends : Practice Patterns, Physicians'.
- Betacoronavirus, COVID-19, Humans, SARS-CoV-2.
DOI: 10.1001/jamainternmed.2020.2594
PubMed: 32628242
PubMed Central: PMC7536584
Links to Exploration step
pubmed:32628242Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</title><author><name sortKey="Shehab, Nadine" sort="Shehab, Nadine" uniqKey="Shehab N" first="Nadine" last="Shehab">Nadine Shehab</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Lantana Consulting Group, Atlanta, Georgia.</nlm:affiliation></affiliation></author><author><name sortKey="Lovegrove, Maribeth" sort="Lovegrove, Maribeth" uniqKey="Lovegrove M" first="Maribeth" last="Lovegrove">Maribeth Lovegrove</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation></author><author><name sortKey="Budnitz, Daniel S" sort="Budnitz, Daniel S" uniqKey="Budnitz D" first="Daniel S" last="Budnitz">Daniel S. Budnitz</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32628242</idno><idno type="pmid">32628242</idno><idno type="doi">10.1001/jamainternmed.2020.2594</idno><idno type="pmc">PMC7536584</idno><idno type="wicri:Area/Main/Corpus">001224</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001224</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</title><author><name sortKey="Shehab, Nadine" sort="Shehab, Nadine" uniqKey="Shehab N" first="Nadine" last="Shehab">Nadine Shehab</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Lantana Consulting Group, Atlanta, Georgia.</nlm:affiliation></affiliation></author><author><name sortKey="Lovegrove, Maribeth" sort="Lovegrove, Maribeth" uniqKey="Lovegrove M" first="Maribeth" last="Lovegrove">Maribeth Lovegrove</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation></author><author><name sortKey="Budnitz, Daniel S" sort="Budnitz, Daniel S" uniqKey="Budnitz D" first="Daniel S" last="Budnitz">Daniel S. Budnitz</name><affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">JAMA internal medicine</title><idno type="eISSN">2168-6114</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Infective Agents (pharmacology)</term><term>Azithromycin (pharmacology)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Chloroquine (pharmacology)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Databases, Pharmaceutical (statistics & numerical data)</term><term>Drug Prescriptions (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (pharmacology)</term><term>Outpatients (statistics & numerical data)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (prevention & control)</term><term>Practice Patterns, Physicians' (trends)</term><term>Pre-Exposure Prophylaxis (methods)</term><term>Prescription Drug Monitoring Programs (statistics & numerical data)</term><term>SARS-CoV-2 (MeSH)</term><term>United States (epidemiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Infective Agents</term><term>Azithromycin</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Pre-Exposure Prophylaxis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Pharmaceutical</term><term>Drug Prescriptions</term><term>Outpatients</term><term>Prescription Drug Monitoring Programs</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Humans</term><term>SARS-CoV-2</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32628242</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>10</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</ArticleTitle><Pagination><MedlinePgn>1384-1386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.2594</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shehab</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lantana Consulting Group, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovegrove</LastName><ForeName>Maribeth</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budnitz</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062313" MajorTopicYN="N">Databases, Pharmaceutical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065129" MajorTopicYN="N">Pre-Exposure Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073958" MajorTopicYN="N">Prescription Drug Monitoring Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32628242</ArticleId><ArticleId IdType="pii">2767895</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2020.2594</ArticleId><ArticleId IdType="pmc">PMC7536584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Coll Cardiol. 2020 May 26;75(20):2623-2624</Citation><ArticleIdList><ArticleId IdType="pubmed">32283123</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2020 Aug 1;180(8):1116-1118</Citation><ArticleIdList><ArticleId IdType="pubmed">32347895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001224 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001224 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32628242
|texte= US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32628242" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |